LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets.
This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the system’s success, and clinical data on that formula reinforcing its effectiveness in supporting GLP-1 production.
The MB System™, as the product is known internationally, launched on March 15 for both LifeVantage Consultants and Customers in Japan. On the same date, it became available exclusively to Consultants in Australia, New Zealand, Europe, UK, Mexico, and Thailand; Customers in these regions gain access starting April 25.
The MB System™ is designed to naturally activate the body’s own GLP-1 production, providing a range of long-term health benefits that expand to weight management and beyond.*
“Consumers worldwide are seeking sustainable health solutions that go beyond short-term, unsustainable weight management. The MB System™ works harmoniously with the body, empowering individuals to naturally enhance their metabolic health in alignment with their lifestyle and wellness objectives,”*
shared Steve Fife, President and CEO of LifeVantage.
Meeting a Growing Global Demand
Interest in GLP-1 and metabolic health is rising worldwide. The global GLP-1 pharmaceutical market